Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7035 | 1413 | 48.8 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
237 | 3 | INFLUENZA//RESPIRATORY SYNCYTIAL VIRUS//AVIAN INFLUENZA | 47995 |
76 | 2 | INFLUENZA//AVIAN INFLUENZA//INFLUENZA VIRUS | 27762 |
7035 | 1 | PB1 F2//NS1//INFLUENZA A VIRUS | 1413 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PB1 F2 | authKW | 271508 | 1% | 74% | 17 |
2 | NS1 | authKW | 225555 | 3% | 25% | 41 |
3 | INFLUENZA A VIRUS | authKW | 217741 | 8% | 9% | 113 |
4 | INFLUENZA VIRUS | authKW | 191522 | 10% | 6% | 141 |
5 | GLOBAL HLTH EMERGING PATHOGENS | address | 153599 | 3% | 17% | 43 |
6 | NS1 PROTEIN | authKW | 123794 | 1% | 30% | 19 |
7 | INFLUENZA VIRUS NS1 PROTEIN | authKW | 111128 | 0% | 86% | 6 |
8 | PB1 F2 PROTEIN | authKW | 108043 | 0% | 100% | 5 |
9 | INNOVAT MED TECHNOL PHARMACEUT | address | 86435 | 0% | 100% | 4 |
10 | INFLUENZA | address | 75213 | 5% | 5% | 75 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 53556 | 47% | 0% | 659 |
2 | Immunology | 2850 | 23% | 0% | 320 |
3 | Microbiology | 908 | 12% | 0% | 167 |
4 | Infectious Diseases | 469 | 6% | 0% | 87 |
5 | Cell Biology | 462 | 11% | 0% | 157 |
6 | Biochemistry & Molecular Biology | 305 | 16% | 0% | 232 |
7 | Biotechnology & Applied Microbiology | 291 | 8% | 0% | 106 |
8 | Parasitiology | 256 | 3% | 0% | 41 |
9 | Respiratory System | 180 | 4% | 0% | 50 |
10 | Medicine, Research & Experimental | 94 | 4% | 0% | 60 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GLOBAL HLTH EMERGING PATHOGENS | 153599 | 3% | 17% | 43 |
2 | INNOVAT MED TECHNOL PHARMACEUT | 86435 | 0% | 100% | 4 |
3 | INFLUENZA | 75213 | 5% | 5% | 75 |
4 | MOL BIOL INFLAMMAT ZMBE | 62215 | 1% | 24% | 12 |
5 | WASHINGTON PRIMATE | 62117 | 2% | 9% | 31 |
6 | MOL VIROL IMV | 57620 | 0% | 67% | 4 |
7 | VET BIOPROD CHEM MED | 49388 | 0% | 57% | 4 |
8 | INT INFECT DIS | 46109 | 2% | 6% | 34 |
9 | BEIRNE B CARTER IMMUNOL | 45315 | 1% | 13% | 16 |
10 | ANIM OURCE EPIDEM DIS PREVENT LIAONI | 43217 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF VIROLOGY | 23990 | 15% | 1% | 210 |
2 | VIROLOGY JOURNAL | 8693 | 2% | 1% | 35 |
3 | JOURNAL OF GENERAL VIROLOGY | 7848 | 5% | 1% | 70 |
4 | INFLUENZA AND OTHER RESPIRATORY VIRUSES | 7419 | 1% | 2% | 17 |
5 | FUTURE VIROLOGY | 4650 | 1% | 2% | 13 |
6 | ANTIVIRAL RESEARCH | 4506 | 2% | 1% | 27 |
7 | PLOS PATHOGENS | 4502 | 2% | 1% | 34 |
8 | VIRAL IMMUNOLOGY | 4232 | 1% | 1% | 15 |
9 | VIROLOGY | 3194 | 4% | 0% | 53 |
10 | CELLULAR MICROBIOLOGY | 1790 | 1% | 1% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PB1 F2 | 271508 | 1% | 74% | 17 | Search PB1+F2 | Search PB1+F2 |
2 | NS1 | 225555 | 3% | 25% | 41 | Search NS1 | Search NS1 |
3 | INFLUENZA A VIRUS | 217741 | 8% | 9% | 113 | Search INFLUENZA+A+VIRUS | Search INFLUENZA+A+VIRUS |
4 | INFLUENZA VIRUS | 191522 | 10% | 6% | 141 | Search INFLUENZA+VIRUS | Search INFLUENZA+VIRUS |
5 | NS1 PROTEIN | 123794 | 1% | 30% | 19 | Search NS1+PROTEIN | Search NS1+PROTEIN |
6 | INFLUENZA VIRUS NS1 PROTEIN | 111128 | 0% | 86% | 6 | Search INFLUENZA+VIRUS+NS1+PROTEIN | Search INFLUENZA+VIRUS+NS1+PROTEIN |
7 | PB1 F2 PROTEIN | 108043 | 0% | 100% | 5 | Search PB1+F2+PROTEIN | Search PB1+F2+PROTEIN |
8 | PR8 | 49388 | 0% | 57% | 4 | Search PR8 | Search PR8 |
9 | AVIAN INFLUENZA VIRUS INFECTION | 43217 | 0% | 100% | 2 | Search AVIAN+INFLUENZA+VIRUS+INFECTION | Search AVIAN+INFLUENZA+VIRUS+INFECTION |
10 | CELLULAR DRUG TARGETS | 43217 | 0% | 100% | 2 | Search CELLULAR+DRUG+TARGETS | Search CELLULAR+DRUG+TARGETS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HALE, BG , RANDALL, RE , ORTIN, J , JACKSON, D , (2008) THE MULTIFUNCTIONAL NS1 PROTEIN OF INFLUENZA A VIRUSES.JOURNAL OF GENERAL VIROLOGY. VOL. 89. ISSUE . P. 2359-2376 | 92 | 64% | 504 |
2 | AYLLON, J , GARCIA-SASTRE, A , (2015) THE NS1 PROTEIN: A MULTITASKING VIRULENCE FACTOR.INFLUENZA PATHOGENESIS AND CONTROL - VOL II. VOL. 386. ISSUE . P. 73 -107 | 105 | 58% | 20 |
3 | ENGEL, DA , (2013) THE INFLUENZA VIRUS NS1 PROTEIN AS A THERAPEUTIC TARGET.ANTIVIRAL RESEARCH. VOL. 99. ISSUE 3. P. 409-416 | 72 | 75% | 15 |
4 | MARC, D , (2014) INFLUENZA VIRUS NON-STRUCTURAL PROTEIN NS1: INTERFERON ANTAGONISM AND BEYOND.JOURNAL OF GENERAL VIROLOGY. VOL. 95. ISSUE . P. 2594 -2611 | 87 | 54% | 11 |
5 | HALE, BG , ALBRECHT, RA , GARCIA-SASTRE, A , (2010) INNATE IMMUNE EVASION STRATEGIES OF INFLUENZA VIRUSES.FUTURE MICROBIOLOGY. VOL. 5. ISSUE 1. P. 23-41 | 89 | 49% | 40 |
6 | MARC, D , (2012) THE MULTIFUNCTIONAL ASPECTS OF THE NS1 PROTEIN OF INFLUENZA A VIRUS.VIROLOGIE. VOL. 16. ISSUE 2. P. 95-106 | 63 | 69% | 0 |
7 | RAMOS, I , FERNANDEZ-SESMA, A , (2012) INNATE IMMUNITY TO H5N1 INFLUENZA VIRUSES IN HUMANS.VIRUSES-BASEL. VOL. 4. ISSUE 12. P. 3363-3388 | 79 | 52% | 10 |
8 | PINTO, R , HEROLD, S , CAKAROVA, L , HOEGNER, K , LOHMEYER, J , PLANZ, O , PLESCHKA, S , (2011) INHIBITION OF INFLUENZA VIRUS-INDUCED NF-KAPPAB AND RAF/MEK/ERK ACTIVATION CAN REDUCE BOTH VIRUS TITERS AND CYTOKINE EXPRESSION SIMULTANEOUSLY IN VITRO AND IN VIVO.ANTIVIRAL RESEARCH. VOL. 92. ISSUE 1. P. 45-56 | 46 | 70% | 35 |
9 | LAM, WY , YEUNG, ACM , CHAN, PKS , (2011) APOPTOSIS, CYTOKINE AND CHEMOKINE INDUCTION BY NON-STRUCTURAL 1 (NS1) PROTEINS ENCODED BY DIFFERENT INFLUENZA SUBTYPES.VIROLOGY JOURNAL. VOL. 8. ISSUE . P. - | 49 | 71% | 9 |
10 | SHORT, KR , KROEZE, EJBV , FOUCHIER, RAM , KUIKEN, T , (2014) PATHOGENESIS OF INFLUENZA-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME.LANCET INFECTIOUS DISEASES. VOL. 14. ISSUE 1. P. 57 -69 | 53 | 42% | 45 |
Classes with closest relation at Level 1 |